Learning objectives:

1.  Briefly review pharmacology, mechanism of action of hydroxychloroquine. 

2. Review the literature regarding hydroxychloroquine dose reduction and effect on disease activity in SLE. 

3. Propose and discuss feasibility of study based on our own experience with hydroxychloroquine dose reduction in setting of new AAO guidelines. 

Speaker Name: 
Dr. Jon Golenbiewski
3031 Duke South
Durham, NC 27701
United States
Session date: 
Tuesday, May 29, 2018 - 8:00am to 9:00am
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 Attendance

Please login or register to take this course.